Temat: "Chemotherapy" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
Autorzy :: Belkouz A; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Wilmink JW; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Haj Mohammad N; UMC Utrecht Cancer Center/RAKU, Dept. of Medical Oncology, Utrecht University, Utrecht, the Netherlands.
Hagendoorn J; UMC Utrecht Cancer Center/RAKU, Dept. of Surgery, Utrecht University, Utrecht the Netherlands.
de Vos-Geelen J; Maastricht UMC+, GROW - School for Oncology and Developmental Biology, Dept. Internal Medicine, Div. of of Medical Oncology, Maastricht, the Netherlands.
Dejong CHC; Department of Surgery and School of Nutrition and Translational Research in Metabolism, Maastricht UMC+, Maastricht, the Netherlands and Department of Surgery, Universitätsklinikum Aachen, Aachen, Germany.
Homs MYV; Erasmus MC, Dept. of Medical Oncology, Rotterdam, the Netherlands.
Groot Koerkamp B; Erasmus MC, Dept. of Surgery Rotterdam, the Netherlands.
van Gulik TM; Amsterdam UMC, Dept. of Surgery, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
van Oijen MGH; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Punt CJA; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Klümpen H; Amsterdam UMC, Dept. of Medical Oncology, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands. Electronic address: .; Pokaż więcej
Źródło :: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2020 Jul; Vol. 151, pp. 102975. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji :: Journal Article; Review
Journal Info :: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit. Rev. Oncol. Hematol. Subsets: MEDLINE
MeSH Terms :: Chemotherapy, Adjuvant*
Clinical Trials, Phase II as Topic*
Clinical Trials, Phase III as Topic*
Antimetabolites, Antineoplastic/*therapeutic use
Biliary Tract Neoplasms/*therapy
Capecitabine/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols ; Biliary Tract Neoplasms/pathology ; Humans ; Neoplasm Recurrence, Local ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome.
Autorzy :: Bouchacourt B; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Hospital MA; Department of Hematology, Institut Paoli-Calmettes, Marseille, France. .
Zemmour C; Department of Clinical Research & Innovation, Biostatics & Methodology Unit, Institut Paoli-Calmettes, Marseille, France.
Rey J; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
d'Incan E; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Charbonnier A; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Mohty B; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Saillard C; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Bonnet S; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Collignon A; Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
Gelsi-Boyer V; Department of Pathology, Institut Paoli-Calmettes, Marseille, France.
Mozziconacci MJ; Department of Pathology, Institut Paoli-Calmettes, Marseille, France.
Blaise D; Department of Hematology, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.
Vey N; Department of Hematology, Institut Paoli-Calmettes, Aix-Marseille Univ, Marseille, France.; Pokaż więcej
Źródło :: Annals of hematology [Ann Hematol] 2020 Apr; Vol. 99 (4), pp. 773-780. Date of Electronic Publication: 2020 Feb 22.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :: Consolidation Chemotherapy*
Leukemia, Myeloid, Acute/*drug therapy
Aged ; Aged, 80 and over ; Allografts ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Blood Component Transfusion ; Combined Modality Therapy ; Cytarabine/administration & dosage ; Cytarabine/adverse effects ; Daunorubicin/administration & dosage ; Daunorubicin/adverse effects ; Disease-Free Survival ; Female ; Follow-Up Studies ; Hematopoietic Stem Cell Transplantation ; Humans ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Remission Induction ; Retrospective Studies ; Transplantation, Autologous ; Treatment Outcome
SCR Protocol :: HDAC protocol
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: [Efficacy and Safety of Intensive Maintenance Chemotherapy Regimen for Treatment of Children and Adolescents with Lymphoblastic Lymphoma for Stage III-IV].
Autorzy :: Liu YF; Department of Pediatrics, Jinan Municipal People's Hospital, Jinan 271100, Shandong Province,China.
Liu SW; Department of Hematology, Jinan Municipal People's Hospital, Jinan 271100, Shandong Province,China.
Sun XJ; Department Neonatology, Jinan Municipal People's Hospital, Jinan 271100, Shandong Province,China,E-mail: .; Pokaż więcej
Źródło :: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2020 Apr; Vol. 28 (2), pp. 524-528.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN: 1009-2137 (Print) Linking ISSN: 10092137 NLM ISO Abbreviation: Zhongguo Shi Yan Xue Ye Xue Za Zhi Subsets: MEDLINE
MeSH Terms :: Maintenance Chemotherapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Adolescent ; Antineoplastic Combined Chemotherapy Protocols ; Child ; Disease-Free Survival ; Humans ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Retrospective Studies ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Correlation Between Pathologic Complete Response in the Breast and Absence of Axillary Lymph Node Metastases After Neoadjuvant Systemic Therapy.
Autorzy :: Samiei S; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
de Munck L; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
Keymeulen KBMI; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
Simons JM; Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Kooreman LFS; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Siesling S; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Center, University of Twente, Enschede, The Netherlands.
Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Smidt ML; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Pokaż więcej
Źródło :: Annals of surgery [Ann Surg] 2020 Mar; Vol. 271 (3), pp. 574-580.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
Journal Info :: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0372354 Publication Model: Print Cited Medium: Internet ISSN: 1528-1140 (Electronic) Linking ISSN: 00034932 NLM ISO Abbreviation: Ann. Surg. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :: Antineoplastic Combined Chemotherapy Protocols*
Breast Neoplasms/*drug therapy
Breast Neoplasms/*pathology
Breast Neoplasms/*surgery
Neoadjuvant Therapy/*methods
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Chemotherapy, Adjuvant ; Female ; Humans ; Lymphatic Metastasis ; Middle Aged ; Neoplasm Staging
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach.
Autorzy :: Ma F; Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Beijing, 100021, China.
Wang B; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Xue L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Kang W; Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Beijing, 100021, China.
Li Y; Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Beijing, 100021, China.
Li W; Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Beijing, 100021, China.
Liu H; Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Beijing, 100021, China.
Ma S; Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Beijing, 100021, China.
Tian Y; Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Beijing, 100021, China. .; Pokaż więcej
Źródło :: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2020 Aug; Vol. 146 (8), pp. 2135-2142. Date of Electronic Publication: 2020 Apr 18.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J. Cancer Res. Clin. Oncol. Subsets: MEDLINE
MeSH Terms :: Adenocarcinoma/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Neuroendocrine/*drug therapy
Stomach Neoplasms/*drug therapy
Adenocarcinoma/pathology ; Adenocarcinoma/surgery ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carcinoma, Neuroendocrine/pathology ; Carcinoma, Neuroendocrine/surgery ; Case-Control Studies ; Chemotherapy, Adjuvant ; Female ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Retrospective Studies ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery ; Survival Rate ; Treatment Outcome
SCR Disease Name :: Adenocarcinoid tumor
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403.
Autorzy :: Kaplan LD; Medicine/Hematology-Oncology, University of California, San Francisco, San Francisco, California, USA.
Maurer MJ; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota, USA.
Stock W; Medicine, University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA.
Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri, USA.
Fulton N; Medicine, University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA.
Pettinger A; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota, USA.
Byrd JC; Hematology, The Ohio State University, Columbus, Ohio, USA.
Blum KA; Hematology, The Ohio State University, Columbus, Ohio, USA.
LaCasce AS; Medical Oncology, Dana-Farber/Partners CancerCare, Boston, Massachusetts, USA.
Hsi ED; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Liu YT; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
Scott DW; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.
Hurd D; Hematology-Oncology, Wake Forest University Health Sciences, Winston-Salem, North Carolina, USA.
Ruppert AS; Alliance Statistics and Data Center, The Ohio State University, Columbus, Ohio, USA.
Hernandez-Ilizaliturri F; Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Leonard JP; Department of Medicine, Weill Medical College of Cornell University, New York, New York, USA.
Cheson BD; Hematology-Oncology, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.; Pokaż więcej
Źródło :: American journal of hematology [Am J Hematol] 2020 Jun; Vol. 95 (6), pp. 583-593. Date of Electronic Publication: 2020 Apr 06.
Typ publikacji :: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info :: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am. J. Hematol. Subsets: MEDLINE
MeSH Terms :: Consolidation Chemotherapy*
Maintenance Chemotherapy*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Bortezomib/*administration & dosage
Lymphoma, Mantle-Cell/*therapy
Rituximab/*administration & dosage
Adolescent ; Adult ; Aged ; Autografts ; Bortezomib/adverse effects ; Carmustine/administration & dosage ; Cyclophosphamide/administration & dosage ; Etoposide/administration & dosage ; Female ; Humans ; Male ; Middle Aged
SCR Protocol :: CBV protocol
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Should the emphasis be on induction or consolidation therapy in transplant-eligible, newly diagnosed multiple myeloma?
Autorzy :: Krishnan A
Sonneveld P; Pokaż więcej
Źródło :: The Lancet. Haematology [Lancet Haematol] 2020 Jun; Vol. 7 (6), pp. e445-e446.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
MeSH Terms :: Consolidation Chemotherapy*
Induction Chemotherapy*
Stem Cell Transplantation*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*therapy
Humans ; Multiple Myeloma/diagnosis ; Multiple Myeloma/drug therapy ; Transplantation, Autologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia.
Autorzy :: Gupta C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Kaulfuss S; Bayer AG, Berlin, Germany.
Görlich K; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Othman B; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Chaturvedi A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. .
Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. .; Pokaż więcej
Źródło :: Annals of hematology [Ann Hematol] 2020 Jun; Vol. 99 (6), pp. 1415-1417. Date of Electronic Publication: 2020 Apr 15.
Typ publikacji :: Letter
Journal Info :: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :: Mutation*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Isocitrate Dehydrogenase/*antagonists & inhibitors
Isocitrate Dehydrogenase/*genetics
Leukemia, Myeloid, Acute/*drug therapy
Leukemia, Myeloid, Acute/*genetics
Animals ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Consolidation Chemotherapy ; Disease Models, Animal ; Humans ; Induction Chemotherapy ; Leukemia, Myeloid, Acute/diagnosis ; Mice ; Treatment Outcome
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.
Autorzy :: Fokas E; University of Frankfurt, Frankfurt, Germany.; German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Frankfurt, Germany.; Frankfurt Cancer Institute, Frankfurt, Germany.
Allgäuer M; Barmherzige Brüder Hospital Regensburg, Regensburg, Germany.
Polat B; University Hospital of Würzburg, Würzburg, Germany.
Klautke G; Poliklinik Chemnitz, Chemnitz, Germany.
Grabenbauer GG; DiaCura, Klinikum Coburg, Coburg, Germany.
Fietkau R; University of Erlangen-Nürnberg, Erlangen, Germany.
Kuhnt T; University of Leipzig, Leipzig, Germany.
Staib L; Klinikum Esslingen, Esslingen, Germany.
Brunner T; University of Freiburg, Freiburg, Germany.; University of Magdeburg, Magdeburg, Germany.
Grosu AL; University of Freiburg, Freiburg, Germany.
Schmiegel W; Ruhr-University Bochum, Bochum, Germany.
Jacobasch L; Praxis of Haematology and Oncology, Dresden, Germany.
Weitz J; German Cancer Research Center, Heidelberg, Germany.; University of Dresden, Dresden, Germany.; German Cancer Consortium, Dresden, Germany.
Folprecht G; German Cancer Research Center, Heidelberg, Germany.; University of Dresden, Dresden, Germany.; German Cancer Consortium, Dresden, Germany.
Schlenska-Lange A; German Cancer Research Center, Heidelberg, Germany.
Flentje M; University Hospital of Würzburg, Würzburg, Germany.
Germer CT; University Hospital of Würzburg, Würzburg, Germany.
Grützmann R; University of Erlangen-Nürnberg, Erlangen, Germany.
Schwarzbach M; Klinikum Frankfurt Höchst, Frankfurt, Germany.
Paolucci V; Ketteler Krankenhaus, Offenbach, Germany.
Bechstein WO; University of Frankfurt, Frankfurt, Germany.
Friede T; University Medical Center Göttingen, Göttingen, Germany.
Ghadimi M; University Medical Center Göttingen, Göttingen, Germany.
Hofheinz RD; University Hospital Mannheim, Mannheim, Germany.
Rödel C; University of Frankfurt, Frankfurt, Germany.; German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Frankfurt, Germany.; Frankfurt Cancer Institute, Frankfurt, Germany.; Pokaż więcej
Corporate Authors :: German Rectal Cancer Study Group
Źródło :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Dec 01; Vol. 37 (34), pp. 3212-3222. Date of Electronic Publication: 2019 May 31.
Typ publikacji :: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J. Clin. Oncol. Subsets: MEDLINE
MeSH Terms :: Chemoradiotherapy, Adjuvant*/adverse effects
Chemoradiotherapy, Adjuvant*/mortality
Consolidation Chemotherapy*/adverse effects
Consolidation Chemotherapy*/mortality
Induction Chemotherapy*/adverse effects
Induction Chemotherapy*/mortality
Neoadjuvant Therapy*/adverse effects
Neoadjuvant Therapy*/mortality
Radiation Dosage*
Adenocarcinoma/*therapy
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Rectal Neoplasms/*therapy
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Administration Schedule ; Female ; Germany ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Rectal Neoplasms/mortality ; Rectal Neoplasms/pathology ; Time Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma.
Autorzy :: Chen J; aInstitute of Cancer and Basic Medicine, Chinese Academy of Sciences bDepartment of Radiation Oncology, Cancer Hospital of the University of Chinese Academy of Sciences cDepartment of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, China.
Liu T
Sun Q
Jin T; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Jul 17; Vol. 99 (29), pp. e20443.
Typ publikacji :: Clinical Trial; Comparative Study; Journal Article
Journal Info :: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :: Chemoradiotherapy/*methods
Chemotherapy, Adjuvant/*methods
Nasopharyngeal Carcinoma/*drug therapy
Nasopharyngeal Carcinoma/*radiotherapy
Nasopharyngeal Neoplasms/*pathology
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; Chemoradiotherapy/adverse effects ; Chemotherapy, Adjuvant/adverse effects ; Combined Modality Therapy/methods ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/mortality ; Neoplasm Staging ; Prognosis ; Radiotherapy, Intensity-Modulated/adverse effects ; Radiotherapy, Intensity-Modulated/methods ; Retrospective Studies ; Survival Rate ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Outcomes of concurrent radiotherapy with weekly docetaxel and platinum-based chemotherapy in stage III non-small-cell lung cancer.
Autorzy :: Kaderbhaï CG; Department of medical oncology, Cancer Center GF Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France. Electronic address: .
Coudert B; Department of medical oncology, Cancer Center GF Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France.
Bertaut A; Biostatistics unit Cancer Center GF Leclerc, Dijon, France; Inserm, LNC UMR1231, Dijon, France.
Adnet J; Biostatistics unit Cancer Center GF Leclerc, Dijon, France.
Favier L; Department of medical oncology, Cancer Center GF Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France.
Lagrange A; Department of medical oncology, Cancer Center GF Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France.
Peignaux-Casasnovas K; Department of radiation oncology, Cancer Center GF Leclerc, Dijon, France.
Mettey L; Department of radiology, CHU, Dijon, France.
Tharin Z; Department of medical oncology, Cancer Center GF Leclerc, 1, rue du Professeur-Marion, 21000 Dijon, France.
Foucher P; Department of thoracic oncology CHU, Dijon, France.
Martin E; Department of radiation oncology, Cancer Center GF Leclerc, Dijon, France.; Pokaż więcej
Źródło :: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2020 Jul; Vol. 24 (4), pp. 279-287. Date of Electronic Publication: 2020 May 18.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Elsevier Country of Publication: France NLM ID: 9711272 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6658 (Electronic) Linking ISSN: 12783218 NLM ISO Abbreviation: Cancer Radiother Subsets: MEDLINE
MeSH Terms :: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*therapy
Chemoradiotherapy/*methods
Lung Neoplasms/*therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin/administration & dosage ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Chemoradiotherapy/adverse effects ; Cisplatin/administration & dosage ; Docetaxel/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Induction Chemotherapy/methods ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Radiotherapy Dosage ; Retrospective Studies ; Survival Rate ; Time Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Advice Regarding Systemic Therapy in Patients with Urological Cancers During the COVID-19 Pandemic.
Autorzy :: Gillessen S; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland. Electronic address: .
Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK. Electronic address: .; Pokaż więcej
Źródło :: European urology [Eur Urol] 2020 Jun; Vol. 77 (6), pp. 667-668. Date of Electronic Publication: 2020 Apr 17.
Typ publikacji :: Editorial
Journal Info :: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur. Urol. Subsets: MEDLINE
MeSH Terms :: Disease Transmission, Infectious*/prevention & control
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Betacoronavirus/*pathogenicity
Coronavirus Infections/*virology
Pneumonia, Viral/*virology
Urologic Neoplasms/*drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Clinical Decision-Making ; Coronavirus Infections/mortality ; Coronavirus Infections/prevention & control ; Coronavirus Infections/transmission ; Humans ; Neoadjuvant Therapy ; Palliative Care ; Pandemics/prevention & control ; Pneumonia, Viral/mortality ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/transmission ; Practice Guidelines as Topic ; Risk Assessment ; Risk Factors ; Treatment Outcome ; Urologic Neoplasms/mortality
SCR Disease Name :: COVID-19
SCR Organism :: severe acute respiratory syndrome coronavirus 2
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Autorzy :: Shu CA; Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Gainor JF; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Awad MM; Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Chiuzan C; Department of Biostatistics, Columbia University Irving Medical Center, New York, NY, USA.
Grigg CM; Levine Cancer Institute, Charlotte, NC, USA.
Pabani A; Tom Baker Cancer Center, Calgary, AB, Canada.
Garofano RF; Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Stoopler MB; Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Cheng SK; Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY, USA.
White A; Division of Thoracic Surgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Lanuti M; Center for Thoracic Cancers, Division of Thoracic Surgery, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
D'Ovidio F; Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Bacchetta M; Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Sonett JR; Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.
Saqi A; Department of Pathology, Columbia University Irving Medical Center, New York, NY, USA.
Rizvi NA; Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: .; Pokaż więcej
Źródło :: The Lancet. Oncology [Lancet Oncol] 2020 Jun; Vol. 21 (6), pp. 786-795. Date of Electronic Publication: 2020 May 07.
Typ publikacji :: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info :: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol. Subsets: MEDLINE
MeSH Terms :: Neoadjuvant Therapy*/adverse effects
Pneumonectomy*/adverse effects
Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Agents, Immunological/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Programmed Cell Death 1 Receptor/*antagonists & inhibitors
Aged ; Albumins/administration & dosage ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Boston ; Carboplatin/administration & dosage ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/pathology ; Chemotherapy, Adjuvant ; Female ; Humans ; Lung Neoplasms/immunology ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; New York City ; Paclitaxel/administration & dosage ; Programmed Cell Death 1 Receptor/immunology ; Time Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis.
Autorzy :: Parmar A; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Chaves-Porras J; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Saluja R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Perry K; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Rahmadian AP; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Santos SD; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Ko YJ; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Berry S; Kingston Health Sciences Centre, Queen's University, Kingston, ON, Canada.
Doherty M; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Chan KKW; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Canadian Centre for Applied Research in Cancer Control, Toronto, ON, Canada. Electronic address: .; Pokaż więcej
Źródło :: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2020 Jan; Vol. 145, pp. 102817. Date of Electronic Publication: 2019 Oct 23.
Typ publikacji :: Journal Article; Meta-Analysis; Systematic Review
Journal Info :: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit. Rev. Oncol. Hematol. Subsets: MEDLINE
MeSH Terms :: Adenocarcinoma*/drug therapy
Adenocarcinoma*/surgery
Chemotherapy, Adjuvant*
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/surgery
Albumins ; Antineoplastic Combined Chemotherapy Protocols ; Capecitabine ; Humans ; Network Meta-Analysis ; Paclitaxel
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Collagen gel droplet-embedded culture drug sensitivity test (CD-DST) predicts the effect of adjuvant chemotherapy on pancreatic cancer.
Autorzy :: Ariake K; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Motoi F; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. .
Mizuma M; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Ohtsuka H; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Hayashi H; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Nakagawa K; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Hata T; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Mitachi K; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Naitoh T; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Kamei T; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Unno M; Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.; Pokaż więcej
Źródło :: Surgery today [Surg Today] 2019 Dec; Vol. 49 (12), pp. 1035-1043. Date of Electronic Publication: 2019 Jul 02.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Springer International Country of Publication: Japan NLM ID: 9204360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-2813 (Electronic) Linking ISSN: 09411291 NLM ISO Abbreviation: Surg. Today Subsets: MEDLINE
MeSH Terms :: Chemotherapy, Adjuvant*
Collagen*
Antimetabolites, Antineoplastic/*pharmacology
Drug Screening Assays, Antitumor/*methods
Fluorouracil/*pharmacology
Pancreatic Neoplasms/*pathology
Pancreatic Neoplasms/*therapy
Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Drug Combinations ; Drug Resistance, Neoplasm ; Female ; Gels ; Humans ; Male ; Neoplasm Recurrence, Local ; Oxonic Acid/administration & dosage ; Oxonic Acid/pharmacology ; Pancreatic Neoplasms/mortality ; Predictive Value of Tests ; Retrospective Studies ; Survival Rate ; Tegafur/administration & dosage ; Tegafur/pharmacology ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.
Autorzy :: Park JR; Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington.; University of Washington, Seattle.
Kreissman SG; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
London WB; Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.
Naranjo A; Department of Biostatistics, University of Florida, Children's Oncology Group Statistics and Data Center, Gainesville.
Cohn SL; Department of Pediatrics, University of Chicago, Chicago, Illinois.
Hogarty MD; Department of Pediatrics Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Tenney SC; Department of Biostatistics, University of Florida, Children's Oncology Group Statistics and Data Center, Gainesville.
Haas-Kogan D; Department of Radiation Oncology, Dana Farber/Brigham and Women's Cancer Center and Harvard Medical School, Boston, Massachusetts.
Shaw PJ; Bone Marrow Transplant, Children's Hospital at Westmead, Sydney, Australia.
Kraveka JM; Department of Pediatrics, Medical University of South Carolina, Charleston.
Roberts SS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, Manhattan, New York.
Geiger JD; Section of Pediatric Surgery, CS Mott Children's Hospital, Michigan Medicine, Ann Arbor.
Doski JJ; Departments of Surgery and Pediatrics, UT Health San Antonio, San Antonio, Texas.
Voss SD; Department of Radiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Maris JM; Department of Pediatrics Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Grupp SA; Department of Pediatrics Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Diller L; Department of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.; Pokaż więcej
Źródło :: JAMA [JAMA] 2019 Aug 27; Vol. 322 (8), pp. 746-755.
Typ publikacji :: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info :: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :: Induction Chemotherapy*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Neuroblastoma/*therapy
Stem Cell Transplantation/*methods
Adolescent ; Adult ; Child ; Child, Preschool ; Combined Modality Therapy ; Consolidation Chemotherapy ; Disease-Free Survival ; Female ; Humans ; Infant ; Intention to Treat Analysis ; Male ; Neuroblastoma/drug therapy ; Proportional Hazards Models ; Risk ; Transplantation, Autologous ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma.
Autorzy :: Hyung J; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Hong JY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim S; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Park JS; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Park CS; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Lee SW; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Kim JH; Department of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Ryu JS; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Huh J; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Suh C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. .; Pokaż więcej
Źródło :: Annals of hematology [Ann Hematol] 2019 Jul; Vol. 98 (7), pp. 1657-1664. Date of Electronic Publication: 2019 Apr 15.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann. Hematol. Subsets: MEDLINE
MeSH Terms :: Central Nervous System Neoplasms*/mortality
Central Nervous System Neoplasms*/therapy
Induction Chemotherapy*
Lymphoma*/mortality
Lymphoma*/therapy
Registries*
Stem Cell Transplantation*
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Aged ; Autografts ; Busulfan/administration & dosage ; Consolidation Chemotherapy ; Cyclophosphamide/administration & dosage ; Disease-Free Survival ; Etoposide/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prospective Studies ; Survival Rate ; Thiotepa/administration & dosage
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: [Prognostic significance and risk factors of minimal residual disease ≥1% on 19th day of induction chemotherapy in children with acute lymphoblastic leukemia].
Autorzy :: Yu J; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Affiliated Shenzhen Maternity and Child Healthcare Hospital, Southern Medical University, Shenzhen 518028, China.
Yi T; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Lin G; Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, China.
Wen J; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Chen L; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Chen J; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Wu X; Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.; Pokaż więcej
Źródło :: Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2020 Feb 29; Vol. 40 (2), pp. 255-261.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Nanfang yi ke da xue xue bao bian ji bu Country of Publication: China NLM ID: 101266132 Publication Model: Print Cited Medium: Print ISSN: 1673-4254 (Print) Linking ISSN: 16734254 NLM ISO Abbreviation: Nan Fang Yi Ke Da Xue Xue Bao Subsets: MEDLINE
MeSH Terms :: Induction Chemotherapy*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Child ; Child, Preschool ; China ; Disease-Free Survival ; Female ; Humans ; Infant ; Male ; Neoplasm, Residual ; Prognosis ; Retrospective Studies ; Risk Factors ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: [Medicinal treatment of pancreatic cancer : Still a domain of chemotherapy?]
Transliterated Title :: Medikamentöse Therapie des Pankreaskarzinoms : Immer noch eine Domäne der Chemotherapie?
Autorzy :: Feldmann G; Klinik und Poliklinik für Innere Medizin III, CIO Aachen-Bonn-Köln-Düsseldorf, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. .; Pokaż więcej
Źródło :: Der Internist [Internist (Berl)] 2020 Feb; Vol. 61 (2), pp. 226-232.
Typ publikacji :: Journal Article; Review
Journal Info :: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0264620 Publication Model: Print Cited Medium: Internet ISSN: 1432-1289 (Electronic) Linking ISSN: 00209554 NLM ISO Abbreviation: Internist (Berl) Subsets: MEDLINE
MeSH Terms :: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Pancreatic Neoplasms*/drug therapy
Chemotherapy, Adjuvant ; Humans ; Molecular Targeted Therapy
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak.
Autorzy :: Thompson CK; Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
Lee MK
Baker JL
Attai DJ
DiNome ML; Pokaż więcej
Źródło :: Annals of surgery [Ann Surg] 2020 Aug; Vol. 272 (2), pp. e96-e97.
Typ publikacji :: Journal Article
Journal Info :: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0372354 Publication Model: Print Cited Medium: Internet ISSN: 1528-1140 (Electronic) Linking ISSN: 00034932 NLM ISO Abbreviation: Ann. Surg. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :: Antineoplastic Agents, Hormonal/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Coronavirus Infections/*epidemiology
Pneumonia, Viral/*epidemiology
Receptors, Estrogen/*metabolism
Betacoronavirus ; Biomarkers, Tumor/analysis ; Breast Neoplasms/metabolism ; Breast Neoplasms/surgery ; Chemotherapy, Adjuvant ; Female ; Humans ; Neoadjuvant Therapy ; Neoplasm Staging ; Pandemics ; Triage
SCR Disease Name :: COVID-19
SCR Organism :: severe acute respiratory syndrome coronavirus 2
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Chemotherapy"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język